Jason Winchester

Federal Circuit Revives Induced Infringement Claims Despite "Skinny Label" Carve-Out

FTC Weighs In On Orange Book Listing Of Drug-Device Patents

USPTO Seeks Public Input On Improving Patent "Robustness And Reliability"

Tillis Urges FDA, USPTO To Investigate Potential False Narrative By Drug Critics

Inducement Suit Proceeds Against Insurance Company For Encouraging Use Of Generic Drug

Executive Order On Promoting Competition In The American Economy: A Focus On Patent And Drug Law To Reduce Health Care Spending

Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced Infringement

FTC Notches Win In Fifth Circuit Reverse Payment Patent Settlement Case

美国联邦巡回法院支持在美国药品价格竞争与专利期补偿法案（Hatch-Waxman Act）

Federal Circuit Upholds Broad Hatch-Waxman Venue Options For Innovator Pharmaceutical Companies